Skip to main content

Prostaglandins & Other Lipid Mediators

  • ISSN: 1098-8823

Editor-In-Chief: Schwartzman

Next planned ship date: May 10, 2024

  • 5 Year impact factor: 2.9
  • Impact factor: 2.9

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clin… Read more

Subscription options

Next planned ship date:
May 10, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators.



Prostaglandins & Other Lipid Mediators invites reports of original research, mini-reviews, reviews, and methods articles in the basic and clinical aspects of all areas of lipid mediator research: cell biology, developmental biology, genetics, molecular biology, chemistry, biochemistry, physiology, pharmacology, endocrinology, biology, the medical sciences, and epidemiology.

Prostaglandins & Other Lipid Mediators also accepts proposals for special issue topics. The Editors will make every effort to advise authors of the decision on the submitted manuscript within 3-4 weeks of receipt.

US National Institutes of Health (NIH) voluntary posting ("Public Access") policy
Prostaglandins & Other Lipid Mediators and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center